CHASE Graduate Academy: Diving into the graduate talent pool
Words by Graham Hawthorn, Managing Director and Kate O’Neill, Graduate Recruitment Lead
With over 2 million students studying at more than 130 UK Universities, the...
Is being easily influenced really that bad? Asks Ryan Wooller, Head of Business Development...
Ryan Wooller, Head of Business Development at Star, discusses leadership and the importance of influence.
Recently, I was talking with a client around the challenges...
Emotional intelligence & the psychology of sales
Don’t keep battering away trying to increase sales, let In-Call Selling with Emotional Intelligence unlock your sales potential.
Many of you will have seen the...
Martin Anderson, Owner of Carrot Recruitment, explores the role of flexible resourcing in pharma.
Unlocking Hidden Talent
It’s a fact that many people in the pharmaceutical and healthcare industries still view the recruitment of permanent staff as the only...
Jo Spink: Changing behaviour in pharma
Behaviour change is a concept that takes place in our everyday lives, but only recently have we begun to understand the power of it...
AI in Pharmacovigilance – Re-imagining the ICSR processing
Over the last few decades, we have seen a spurt of medicines approved by regulatory authorities which have necessitated an increase in the need...
Pharmaceutical job opportunities: Star recruits for ground-breaking product launch
Star, the UK's first choice outsourcing and resourcing provider to the pharmaceutical, medical device and healthcare industries is delighted to announce a new partnership. Through...
Pf Award Winner & Regional Business Manager at Star, Greg Palin, on building the...
Congratulations on your Pf Award win, how did it feel when your name was announced as winner of the Emerging Talent Award?
A shock!...
High-cost orphan drugs in Europe – a ray of hope or a bottomless...
What does the future hold for orphan drugs?
The Brexit effect: What is happening to the UK science industry?
It’s still impossible to know the full effect of the Brexit referendum on the UK science industry. The vote to leave the European Union...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...